A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. (Q48247770)

9 February 2018

title

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. (English)

1 reference

9 February 2018

author name string

Javitt DC

1

1 reference

9 February 2018

Balla A

2

1 reference

9 February 2018

Sershen H

3

1 reference

9 February 2018

Lajtha A

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 February 2018

published in

Biological Psychiatry

1 reference

9 February 2018

volume

45

1 reference

9 February 2018

page(s)

668-679

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Amphetamine psychosis: behavioral and biochemical aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Observations on the psychotomimetic effects of Sernyl.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Cellular mechanisms underlying reinforcement-related processing in the nucleus accumbens: electrophysiological studies in behaving animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

7 January 2021

Dissociative Anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

High-affinity transport of gamma-aminobutyric acid, glycine, taurine, L-aspartic acid, and L-glutamic acid in synaptosomal (P2) tissue: a kinetic and substrate specificity analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Functional and anatomical aspects of prefrontal pathology in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The basal ganglia and cognitive pattern generators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Amelioration of negative symptoms in schizophrenia by glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Sernyl (CI-395) in clinical anaesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Drug development and the deficit syndrome of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: a behavioral and microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Model psychoses and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Effects of phencyclidine, pentobarbital, and d-amphetamine on the acquisition and performance of conditional discriminations in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

An involvement of dopamine in higher order choice mechanisms in the monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

d-Cycloserine therapy of psychosis by symptom provocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Phencyclidine in combination with d-amphetamine: differential effects on acquisition and performance of response chains in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Antagonism of phencyclidine-induced hyperactivity by glycine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The effect of amphetamine on delayed response performance in the monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

Glycine transporters are differentially expressed among CNS cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

A linkage study of the N-methyl-D-aspartate receptor subunit gene loci and schizophrenia in southern African Bantu-speaking families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900237-6

10.1016/S0006-3223(98)00237-6

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10187996

1 reference

9 February 2018